Radio and PodcastRadio and PodcastLive Radio & Podcasts
December 2025: Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial artwork
Religion & Spirituality

December 2025: Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial

American Journal of Psychiatry Audio by American Psychiatric Association Publishing

Dec 1, 202522:12Religion & Spirituality

Dr. Suresh Durgam (Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, NJ) joins AJP Audio to discuss a phase 3 randomized controlled trial looking at the use of the antipsychotic medication lumateperone a...

About This Episode

December 2025: Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial is an episode from American Journal of Psychiatry Audio by American Psychiatric Association Publishing...

Podcast

This episode belongs to American Journal of Psychiatry Audio.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Dec 1, 2025, 22:12 long, audio available.

Related Episodes

Continue listening to more episodes from American Journal of Psychiatry Audio.